L. Nathan Tumey

L. Nathan Tumey is an assistant professor of medicinal chemistry in the School of Pharmacy and Pharmaceutical Sciences at Binghamton University. He joined Binghamton University in 2017, following 15 years of experience in the pharmaceutical and biotechnology industry. Between 2009 - 2017 he was a team leader for the ADC discovery efforts at Pfizer. In this role, he led a group of bioconjugation and bioanalytical scientists that designed and synthesized antibody-drug conjugates for use in oncology applications. He received his PhD in chemistry from Duke University in 2001, under the supervision of Michael Pirrung. His research team at Binghamton University focuses on the application of antibody-drug conjugates and related technology for the treatment of auto-immune disorders and rare diseases. Additionally, his lab investigates bioconjugate stability, ADC linker design and new targeted drug-delivery modalities.